HIV protease inhibitor Bevirimat, Purity ≥98%

Cat. No.: X24-06-ZQ992

HIV protease inhibitor Bevirimat, Purity ≥98%

Synonym: 174022-42-5; HIV protease inhibitor; BVM; MPC-4326; PA-457

  • MDL: MFCD00954243
  • CAS Number: 174022-42-5
  • Compound CID: 457928
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Bevirimat, soluble in DMSO and ethanol, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART).
Molecular Weight
584.82
Molecular Formula
C36H56O6
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 90 mg/mL (153.88 mM); Ethanol: <1 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
Bevirimat is evaluated for its ability to inhibit HIV maturation through affecting the viral protease.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0